$PCYO

Pure Cycle Corporation Announces Dates for Year End 2025 Earnings Presentation

DENVER, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Pure Cycle Corporation ( NASDAQ: PCYO ) will release financial results for the year ended August 31, 2025, on Wednesday, November 12, 2025, and hold an earnings presentation on Thursday, November 13, 2025, to discuss the results.

Original reporting
GlobeNewswire · Pure Cycle Corporation
Published Nov 5, 2025, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 5, 2025, 2:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$PCYO
Neutral
medium confidence
Mentioned
$PCYO
alphai data visualization · based on GlobeNewswire
Decision brief

The 30-second read

$PCYONeutralMed
01

Why it matters

Earnings results are expected to provide clarity on the company's financial health and growth prospects.

02

Market read

High relevance for investors and traders focusing on water utilities and related sectors.

03

What to watch

Market-wide macroeconomic conditions and sector trends could overshadow company-specific news.

Timing: High, as the earnings release and presentation are scheduled for next week.

Background

Pure Cycle Corporation specializes in water and wastewater services, with recent sector developments influencing investor sentiment.

Company-level read

Ticker impact

$PCYONeutralMedium confidence
Context

The news pertains directly to Pure Cycle Corporation's upcoming earnings release, which is highly relevant for trading decisions.

Expected impact

Potential for increased volatility around the earnings date; possible upward movement if results surpass expectations, downward if below.

Evidence & confidence

Earnings reports typically impact stock prices; however, without current financial data or analyst forecasts, the exact impact remains uncertain.

Market effects

Positive sentiment towards energy and transportation sectors, potentially benefiting related stocks.

Limited regional impact, primarily affecting US markets where PCYO operates.

Minimal, as the news is company-specific.

Counterpoint

If earnings disappoint, the stock could decline sharply, negating short-term gains.

Key entities

  • Pure Cycle Corporation

    A water services provider listed on NASDAQ.

Related articles

$PCYOMed

PURE CYCLE CORP (PCYO): Results of Operations and Financial Condition

PURE CYCLE CORP (PCYO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pcyo-20260707xex99d1.htm EX-99.1 Exhibit 99.1 ​ Pure Cycle Announces Financial Results For the Three and Nine Months Ended May 31, 2026 and Announces a Board of Directors Transition ​ DENVER, CO / GLOBE NEWSWIRE / July 8, 2026 – Pure Cycle Corporation (NASDAQ Capital Ma

$PCYOMedAI 8/10

Pure Cycle Announces Financial Results For the Three and Nine Months Ended May 31, 2026 and Announces a Board of Directors Transition

Pure Cycle Corp. (PCYO) reported Q3 FY2026 (three months ended May 31, 2026) revenue of $8.2M, up 60% year over year, and net income of $2.9M, up 31%. Nine-month revenue rose to $22.5M (+51%) and net income to $8.6M (+23%). EPS was $0.12 (quarter) and $0.36 (YTD). The company also announced director Daniel R. Kozlowski’s resignation and a board search for a successor.

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.